MedPath

Memory and Fear Study (Fear of Memory Loss Study)

Not Applicable
Completed
Conditions
Anxiety and Fear
Registration Number
NCT04821960
Lead Sponsor
Northwestern University
Brief Summary

This study is a randomized control study to determine the impact of a tailored, web-based mindfulness program to reduce anxiety and increase the quality of life in older adults experiencing dementia-related fears, relative to a conventional meditation program.

Detailed Description

The study will test two different types of online mindfulness programs to see if an online self-paced mindfulness program can help reduce anxiety related to memory loss. Participants will be involved in the study for a total of 10 weeks. Participants will log on to an online mindfulness program 4 days per week for about 10-20 minutes each. The total program will last 3 weeks. Participants will also be asked to complete questionnaires before starting the program, during the program, and after they complete the program.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • 55 years of age or older
  • Elevated dementia-related fear
  • Able to read/write in English
  • Willingness to be randomized to intervention group
  • Willingness to complete three weeks of self-guided intervention, questionnaires, and cognitive tests.
  • Access to a reliable internet connection
Exclusion Criteria
  • Diagnosis of mild cognitive impairment, Alzheimer's Disease, or dementia by a healthcare provider.
  • Impaired cognitive or neurologic function
  • Unstable medical condition
  • Severe depression
  • Current treatment for anxiety or depression
  • Current participation in another psychotherapy
  • Current use of psychiatric medication
  • Current substance use disorder
  • Inadequate vision or hearing to interact with study materials

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fear and Avoidance of Memory Loss (FAM) Scale Score at Follow-up10 Weeks Post-Baseline

A 24-item scale to assess fear of memory loss. Scores range from 24-120 points with a higher score indicating a higher fear of memory loss.

Fear of Alzheimer's Disease Scale (FADS) Score at Follow-up10 Weeks Post-Baseline

A 30-item scale to assess fear of Alzheimer's disease. Minimum score = 0; maximum score = 120. A higher score indicates a greater fear of developing Alzheimer's Disease.

Secondary Outcome Measures
NameTimeMethod
Memory Failure Scale (MFS)10 Week Post-Baseline

A 12-item scale that measures memory failure that people tend to experience in everyday life. Minimum score=12; maximum score= 60. A higher score indicates a greater likelihood of memory failures.

Trial Locations

Locations (1)

Northwestern University

🇺🇸

Chicago, Illinois, United States

Northwestern University
🇺🇸Chicago, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.